PerkinElmer's Q2 Revenues Drop 14 Percent; Shares Hit Hard | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its second-quarter revenues fell 14 percent, or 9 percent on an organic basis, amid continuing constraints on the capital equipment market.

The Waltham, Mass.-based firm brought in revenues of $434.6 million for the three-month period ended July 5, compared to revenues of $505 million for the second quarter of 2008. Analysts, on average, had expected the firm to report revenues of $450.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.